Bulleyanin

CAS No. 123043-54-9

Bulleyanin( —— )

Catalog No. M29287 CAS No. 123043-54-9

Bulleyanin shows strong inhibition of mouse ehrlich ascites carcinoma (ECA), mouse sarcoma S-180, and mouse liver ascites.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 2493 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bulleyanin
  • Note
    Research use only, not for human use.
  • Brief Description
    Bulleyanin shows strong inhibition of mouse ehrlich ascites carcinoma (ECA), mouse sarcoma S-180, and mouse liver ascites.
  • Description
    Bulleyanin shows strong inhibition of mouse ehrlich ascites carcinoma (ECA), mouse sarcoma S-180, and mouse liver ascites.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    123043-54-9
  • Formula Weight
    534.6
  • Molecular Formula
    C28H38O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C=C([C@H]([C@@H](O)[C@@H]1OC(C)=O)C2)C([C@@]32[C@@H](OC(C)=O)C[C@]4([H])C(C)(C)[C@@H](OC(C)=O)C[C@H](OC(C)=O)[C@@]4(C)[C@@]31[H])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?

  • Apelin-15 (63 - 75)

    Apelin-15 (63 - 75)

  • Glyasperin F

    Glyasperin F has antinociceptive, and anti-inflammatory effects, it could inhibit NO production in RAW 264.7 macrophages to some extent.